Sign in Subscribe
United States. Securities and Exchange Commission

SEC Filing Reveals Details of Arrhythmia Research Technology Inc.'s Corporate Changes

Strategic Insights

— 1 min read

U.S. Securities and Exchange Commission (SEC) filings provide critical information for investors and security holders, offering a glimpse into the latest developments within publicly-traded companies. On July 23, 2015, Arrhythmia Research Technology Inc. submitted a Form 8-K filing, detailing three documents and significant corporate changes. This filing marks a crucial moment for the company, as it highlights major events and updates that impact investors.

Key Takeaways:

  • Arrhythmia Research Technology Inc. filed a Form 8-K with the SEC on July 23, 2015, detailing three documents.
  • The company's SIC code is 3845, indicating its primary business activity is in electrophysiology equipment.
  • The SEC filing reveals significant corporate changes that were previously unreported.
  • The Form 8-K provides more current information on these events than would reports filed under Forms 10-Q or 10-K.
  • The filing serves as a "current report" for investors and security holders to stay informed about the company's latest developments.
  • The company's contact information for this filing is 25 SAWYER PASSWAY, FITCHBURG MA 01420, and the phone number is 978-345-5000.

Statistics:

  • There were 3 documents filed with the Form 8-K on July 23, 2015.
  • The SEC file number for this filing is 0000819689-15-000063.
  • The SIC code for Arrhythmia Research Technology Inc. is 3845, Electromedical and Electrotherapeutic Apparatus.

Sources:

  • "U.S. Securities and Exchange Commission filing" by NewsRx, Health & Medicine Week, August 14, 2015.

Read more